Guoying Ni

1.2k total citations
52 papers, 892 citations indexed

About

Guoying Ni is a scholar working on Immunology, Molecular Biology and Microbiology. According to data from OpenAlex, Guoying Ni has authored 52 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 16 papers in Molecular Biology and 12 papers in Microbiology. Recurrent topics in Guoying Ni's work include Immunotherapy and Immune Responses (16 papers), Antimicrobial Peptides and Activities (12 papers) and Immune Response and Inflammation (7 papers). Guoying Ni is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Antimicrobial Peptides and Activities (12 papers) and Immune Response and Inflammation (7 papers). Guoying Ni collaborates with scholars based in China, Australia and Japan. Guoying Ni's co-authors include Tianfang Wang, Xiaosong Liu, Xiaosong Liu, Jianwei Yuan, Hejie Li, Wei Ming, Yuejian Wang, Shelley F. Walton, Shu Chen and Guoqiang Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and FEBS Letters.

In The Last Decade

Guoying Ni

50 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoying Ni China 18 321 310 141 134 115 52 892
Guiwen Yang China 17 461 1.4× 562 1.8× 91 0.6× 102 0.8× 175 1.5× 52 1.1k
Menno J. Oudhoff Canada 18 521 1.6× 297 1.0× 106 0.8× 215 1.6× 34 0.3× 25 1.2k
Irena Adkins Czechia 18 383 1.2× 371 1.2× 170 1.2× 193 1.4× 21 0.2× 32 1.1k
Patrizia Sommi Italy 19 464 1.4× 533 1.7× 50 0.4× 111 0.8× 47 0.4× 45 1.5k
Eric Guenzi Germany 16 616 1.9× 396 1.3× 208 1.5× 123 0.9× 85 0.7× 27 1.8k
Maria E. Lund Australia 15 254 0.8× 203 0.7× 66 0.5× 33 0.2× 56 0.5× 25 762
José Carlos Santos Switzerland 13 1.1k 3.4× 547 1.8× 53 0.4× 146 1.1× 66 0.6× 15 1.5k
Jinlin Liu China 17 264 0.8× 470 1.5× 221 1.6× 208 1.6× 85 0.7× 74 977
Olga M. Ibañez Brazil 20 410 1.3× 497 1.6× 115 0.8× 58 0.4× 165 1.4× 82 1.3k

Countries citing papers authored by Guoying Ni

Since Specialization
Citations

This map shows the geographic impact of Guoying Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoying Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoying Ni more than expected).

Fields of papers citing papers by Guoying Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoying Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoying Ni. The network helps show where Guoying Ni may publish in the future.

Co-authorship network of co-authors of Guoying Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Guoying Ni. A scholar is included among the top collaborators of Guoying Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoying Ni. Guoying Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hejie, et al.. (2025). Host-defence caerin 1.1 and 1.9 peptides suppress B16 melanoma growth by inducing apoptosis and disrupting lipid metabolism. Biomedicine & Pharmacotherapy. 189. 118242–118242. 1 indexed citations
2.
Sun, Juan, Qin Li, Tianfang Wang, et al.. (2025). Effect of Caerin 1.9 Antimicrobial Peptide Gel on Early Bacterial Infections in Oral Titanium Implants: An Animal Study. International Dental Journal. 76(1). 103991–103991.
3.
Li, Junjie, Hejie Li, Xiaosong Liu, et al.. (2024). Caerin 1.1 and 1.9 peptides halt B16 melanoma metastatic tumours via expanding cDC1 and reprogramming tumour macrophages. Journal of Translational Medicine. 22(1). 973–973. 4 indexed citations
5.
Liu, Mengqi, Qin Li, Tianfang Wang, et al.. (2024). Caerin 1.9–Titanium Plates Aid Implant Healing and Inhibit Bacterial Growth in New Zealand Rabbit Mandibles. International Dental Journal. 74(6). 1287–1297. 1 indexed citations
6.
Ni, Guoying, et al.. (2023). Clinical efficacy of PD-1 inhibitor combined with radiotherapy in a multi-drug resistant patient with liver metastasis from gastric cancer. Frontiers in Surgery. 10. 1101294–1101294. 2 indexed citations
7.
He, Tiantian, Juan Du, Keke Zhu, et al.. (2023). Experimental study of 131I-caerin 1.1 and 131I-c(RGD)2 for internal radiation therapy of esophageal cancer xenografts. Biomedicine & Pharmacotherapy. 164. 114891–114891. 4 indexed citations
8.
Li, Junjie, et al.. (2023). Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria. BioDrugs. 37(5). 607–623. 7 indexed citations
9.
Yang, Xiaodan, et al.. (2022). Preclinical Pharmacokinetics, Biodistribution, and Acute Toxicity Evaluation of Caerin 1.9 Peptide in Sprague Dawley Rats. Evidence-based Complementary and Alternative Medicine. 2022. 1–13. 8 indexed citations
10.
Ni, Guoying, et al.. (2022). PEGylated IL-10: Clinical Development in Cancer Immunotherapy, Where to Go?. Current Oncology Reports. 25(2). 115–122. 5 indexed citations
11.
12.
13.
Liu, Na, Lu Zhang, Tiantian He, et al.. (2021). Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice. Annals of Nuclear Medicine. 35(7). 811–822. 13 indexed citations
14.
Ni, Guoying, Shu Chen, Mo Chen, et al.. (2020). Host-Defense Peptides Caerin 1.1 and 1.9 Stimulate TNF-Alpha-Dependent Apoptotic Signals in Human Cervical Cancer HeLa Cells. Frontiers in Cell and Developmental Biology. 8. 676–676. 24 indexed citations
15.
Pan, Xuan, Shuqing Chen, Jialing Wu, et al.. (2019). Synthesized natural peptides from amphibian skin secretions increase the efficacy of a therapeutic vaccine by recruiting more T cells to the tumour site. BMC Complementary and Alternative Medicine. 19(1). 163–163. 20 indexed citations
16.
Chen, Shu, et al.. (2015). Blocking IL-10 signalling at the time of immunization renders the tumour more accessible to T cell infiltration in mice. Cellular Immunology. 300. 9–17. 13 indexed citations
17.
Ni, Guoying, Tianfang Wang, Lin Yang, et al.. (2015). Combining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer management. Human Vaccines & Immunotherapeutics. 12(3). 599–606. 2 indexed citations
18.
Ni, Guoying, Tianfang Wang, Shelley F. Walton, et al.. (2015). Manipulating IL-10 signalling blockade for better immunotherapy. Cellular Immunology. 293(2). 126–129. 58 indexed citations
19.
Chen, Jiezhong, Guoying Ni, & Xiao Song Liu. (2011). Papillomavirus virus like particle-based therapeutic vaccine against human papillomavirus infection related diseases: Immunological problems and future directions. Cellular Immunology. 269(1). 5–9. 27 indexed citations
20.
Ni, Guoying. (2008). Production of high-effect and broadband electromagnetic shielding fabrics. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026